Image via BioSpectrum India
Capital Raisingcurated sourcedetected 2026-06-08 · confidence 95%
Immuneel Therapeutics: Capital Raising
Bengaluru CAR-T therapy company Immuneel Therapeutics closed a Rs 100+ crore (about US$12 million) Series B with Singularity AMC and Rainmatter joining existing backers including Kiran Mazumdar-Shaw, Eight Roads and F-Prime — funding GMP manufacturing scale-up and Qartemi commercialisation.
Source: BioSpectrum India
The leadership read
Manufacturing and operations scaling leadership, regulatory-affairs leads for Asia-Pacific and Middle East market entry, and commercial executives for India's first approved CAR-T therapy.
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Asia signal share is easing (-2.1pts).